Swiss Life Asset Management Ltd Sells 6,972 Shares of Revvity Inc. $RVTY

Swiss Life Asset Management Ltd decreased its holdings in Revvity Inc. (NYSE:RVTY) by 24.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,127 shares of the company’s stock after selling 6,972 shares during the period. Swiss Life Asset Management Ltd’s holdings in Revvity were worth $2,141,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Byrne Asset Management LLC grew its holdings in Revvity by 0.9% during the 4th quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock valued at $1,078,000 after purchasing an additional 100 shares during the last quarter. Trust Point Inc. grew its holdings in Revvity by 3.8% during the 4th quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock valued at $311,000 after purchasing an additional 117 shares during the last quarter. First National Advisers LLC grew its holdings in Revvity by 0.8% during the 3rd quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock valued at $1,317,000 after purchasing an additional 125 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in Revvity by 26.2% during the 4th quarter. Farther Finance Advisors LLC now owns 698 shares of the company’s stock valued at $68,000 after purchasing an additional 145 shares during the last quarter. Finally, Mackenzie Financial Corp grew its holdings in Revvity by 1.7% during the 3rd quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock valued at $785,000 after purchasing an additional 154 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Trading Down 2.3%

Shares of RVTY opened at $94.19 on Friday. The company has a 50-day moving average of $90.31 and a 200 day moving average of $96.93. The firm has a market capitalization of $10.51 billion, a price-to-earnings ratio of 45.07, a PEG ratio of 2.08 and a beta of 1.05. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $118.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the business posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, research analysts expect that Revvity Inc. will post 5.33 EPS for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Analysts Set New Price Targets

A number of research firms recently issued reports on RVTY. Evercore boosted their price objective on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a report on Tuesday, February 3rd. Barclays lifted their target price on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. The Goldman Sachs Group lowered their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research note on Tuesday, April 14th. Stifel Nicolaus lowered their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Finally, Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Four research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Revvity has a consensus rating of “Hold” and an average price target of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.